$-0.14 EPS Expected for OncoSec Medical (ONCS); Nationstar Mortgage Holdings (NSM) Sentiment Is 1.46

May 18, 2018 - By Ellis Scott

OncoSec Medical Incorporated (NASDAQ:ONCS) Logo

Nationstar Mortgage Holdings Inc (NSM) investors sentiment increased to 1.46 in 2017 Q4. It’s up 0.42, from 1.04 in 2017Q3. The ratio is more positive, as 60 institutional investors opened new or increased stock positions, while 41 trimmed and sold equity positions in Nationstar Mortgage Holdings Inc. The institutional investors in our database now hold: 94.30 million shares, down from 95.15 million shares in 2017Q3. Also, the number of institutional investors holding Nationstar Mortgage Holdings Inc in top ten stock positions decreased from 4 to 3 for a decrease of 1. Sold All: 8 Reduced: 33 Increased: 41 New Position: 19.

Analysts expect OncoSec Medical Incorporated (NASDAQ:ONCS) to report $-0.14 EPS on June, 7.They anticipate $0.08 EPS change or 36.36% from last quarter’s $-0.22 EPS. After having $-0.24 EPS previously, OncoSec Medical Incorporated’s analysts see -41.67% EPS growth. The stock decreased 7.30% or $0.13 during the last trading session, reaching $1.65. About 2.78M shares traded or 131.08% up from the average. OncoSec Medical Incorporated (NASDAQ:ONCS) has risen 44.62% since May 18, 2017 and is uptrending. It has outperformed by 33.07% the S&P500.

Ratings analysis reveals 33% of Nationstar Mortgage’s analysts are positive. Out of 3 Wall Street analysts rating Nationstar Mortgage, 1 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. NSM was included in 3 notes of analysts from September 9, 2016. The rating was initiated by Piper Jaffray with “Neutral” on Friday, September 9. Barclays Capital downgraded it to “Underweight” rating and $15.0 target in Thursday, February 23 report. The firm earned “Buy” rating on Wednesday, October 26 by Nomura.

The stock decreased 0.11% or $0.02 during the last trading session, reaching $18.51. About 190,991 shares traded. Nationstar Mortgage Holdings Inc. (NSM) has risen 19.73% since May 18, 2017 and is uptrending. It has outperformed by 8.18% the S&P500.

Nationstar Mortgage Holdings Inc. provides servicing, origination, and transaction based services primarily to single-family residences in the United States. The company has market cap of $1.82 billion. It operates in three divisions: Servicing, Originations, and Xome. It has a 9.77 P/E ratio. The Servicing segment offers conventional residential mortgage loans and home equity conversion loans.

More important recent Nationstar Mortgage Holdings Inc. (NYSE:NSM) news were published by: Globenewswire.com which released: “New Research Coverage Highlights Assurant, Williams Partners, Atmos Energy, Nationstar Mortgage, Applied …” on May 15, 2018, also Seekingalpha.com published article titled: “Nationstar Mortgage Holdings’ (NSM) CEO Jay Bray on Q1 2018 Results – Earnings Call Transcript”, Streetinsider.com published: “Nationstar Mortgage Holdngs (NSM) Promotes Tony Ebers to COO” on April 19, 2018. More interesting news about Nationstar Mortgage Holdings Inc. (NYSE:NSM) was released by: Businesswire.com and their article: “Nationstar Reports First Quarter 2018 Financial Results” with publication date: May 03, 2018.

Analysts await Nationstar Mortgage Holdings Inc. (NYSE:NSM) to report earnings on August, 2. They expect $0.47 earnings per share, up 9.30% or $0.04 from last year’s $0.43 per share. NSM’s profit will be $46.16 million for 9.85 P/E if the $0.47 EPS becomes a reality. After $0.44 actual earnings per share reported by Nationstar Mortgage Holdings Inc. for the previous quarter, Wall Street now forecasts 6.82% EPS growth.

Fortress Investment Group Llc holds 32.71% of its portfolio in Nationstar Mortgage Holdings Inc. for 68.10 million shares. Proxima Capital Management Llc owns 360,137 shares or 3.86% of their US portfolio. Moreover, Sls Management Llc has 3.6% invested in the company for 139,188 shares. The New York-based Garnet Equity Capital Holdings Inc. has invested 2.72% in the stock. Adirondack Research & Management Inc., a New York-based fund reported 272,548 shares.

OncoSec Medical Incorporated, a biotechnology company, engages in developing DNA intratumoral immunotherapies in the United States. The company has market cap of $84.95 million. The company's investigational technology, ImmunoPulseis designed to enhance the local delivery and uptake of DNA immune-targeting agents, such as plasmid encoded IL-12 for the treatment of cancer. It currently has negative earnings. The Company’s lead product candidate, ImmunoPulse IL-12, has demonstrated a favorable safety profile, evidence of anti-tumor activity in the treatment of various solid tumors, and the potential to reach beyond the site of local treatment to initiate a systemic immune response in Phase 1 and 2 clinical trials for metastatic melanoma and triple-negative breast cancer.

Another recent and important OncoSec Medical Incorporated (NASDAQ:ONCS) news was published by Streetinsider.com which published an article titled: “Oncosec Medical (ONCS) Expands Relationship with Merck (MRK); Announces Clinical Collaboration to Evaluate …” on May 08, 2018.

Among 4 analysts covering OncoSec Medical (NASDAQ:ONCS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. OncoSec Medical had 12 analyst reports since March 9, 2016 according to SRatingsIntel. On Monday, April 23 the stock rating was maintained by H.C. Wainwright with “Buy”. The stock of OncoSec Medical Incorporated (NASDAQ:ONCS) earned “Buy” rating by H.C. Wainwright on Wednesday, May 9. Maxim Group maintained the stock with “Buy” rating in Friday, June 2 report. The stock has “Buy” rating by Rodman & Renshaw on Thursday, July 21. The stock of OncoSec Medical Incorporated (NASDAQ:ONCS) earned “Buy” rating by H.C. Wainwright on Friday, January 19. As per Thursday, June 8, the company rating was maintained by Maxim Group. H.C. Wainwright maintained the stock with “Buy” rating in Friday, June 2 report. Noble Financial maintained the shares of ONCS in report on Tuesday, June 13 with “Buy” rating. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, March 9 report. H.C. Wainwright maintained the shares of ONCS in report on Monday, June 12 with “Buy” rating.

Nationstar Mortgage Holdings Inc. (NYSE:NSM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: